Evidence map›Paper›PMID 35659415›Full record

ArticleTrends in neurosciences2022

A novel link between locus coeruleus activity and amyloid-related cognitive decline.

Michael A Kelberman, David Weinshenker

Abstract readComment
In one paragraph

Article in Trends in neurosciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Neurobiophilia.Brain sciences · 2026
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Michael A KelbermanDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA.
David WeinshenkerDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: dweinsh@emory.edu.

Funding

Training In Systems And Integrative Biology NeuroscienceT32NS096050 · NINDS · EMORY UNIVERSITY · PI Yoland Smith · 2016 to 2026
$3.9M
Mechanisms underlying selective vulnerability of locus coeruleus neurons in Alzheimer's diseaseRF1AG061175 · NIA · EMORY UNIVERSITY · PI KANG, SEONG SU, WEINSHENKER, DAVID · 2019 to 2019
$2.8M
Impact of locus coeruleus-derived tau pathology in a rodent model of early Alzheimer's diseaseR01AG062581 · NIA · EMORY UNIVERSITY · PI KEILHOLZ, SHELLA D, WEINSHENKER, DAVID · 2020 to 2024
$2.3M
Local and global consequences of hyperphosphorylated tau in the locus coeruleus in Alzheimer's DiseaseF31AG069502 · NIA · EMORY UNIVERSITY · PI KELBERMAN, MICHAEL · 2020 to 2022
$138k
NIA NIH HHS F31 AG069502NIA NIH HHS R01 AG062581NIA NIH HHS RF1 AG061175NINDS NIH HHS T32 NS096050
6 · The paper itself

Abstract

Recent work from Prokopiou, Engels-Domínguez et al. assessed locus coeruleus (LC) activity and its functional connectivity (FC) to forebrain regions during a novelty task in cognitively unimpaired adult individuals with varying degrees of amyloid deposition. Novelty increased LC activity and LC FC, but lower responses on these measures were associated with steeper cognitive decline in amyloid-positive individuals.

Indexed as

Alzheimer DiseaseCognitive DysfunctionAdultAmyloid beta-PeptidesHumansLocus CoeruleusMagnetic Resonance ImagingPositron-Emission TomographyAmyloid beta-PeptidesagingAlzheimer’s diseasefMRIfunctional connectivitynovelty

Identifiers

PMID35659415
PMCPMC10216710

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.